Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
326 participants
OBSERVATIONAL
2021-09-20
2025-05-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cannabidiol and Older Adult Cannabis Users
NCT06290063
A Study of Cannabidiol in Young Adult Cannabis Users
NCT06569394
Acute Effects of THC in Older Adult
NCT06948136
Behavioral Pharmacology of Cannabis in Older Adults
NCT06055309
Eye Tracking as a Biomarker of Cannabis Effects
NCT04100590
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cannabis Users
Older adults (60 and up) who report pain, sleep problems, and/or negative mood (anxiety and/or depression) and who desire to use cannabis for these issues (n=300)
Choice of cannabis product
Participants choose and purchase their own cannabis product
Cannabis Non-users
Older adults (60 and up) who report pain, sleep problems, and/or negative mood (anxiety and/or depression) and do NOT desire to use cannabis for these issues (n=50)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Choice of cannabis product
Participants choose and purchase their own cannabis product
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to provide informed consent
* Cannabis Users: Must not currently use cannabis more than 7 times per month and not for pain, sleep, depression or anxiety in the past 6 months
* Cannabis Non-users: Should NOT have used cannabis in the past year and have not used regularly (e.g., more than weekly) for more than one year in the past 20 years
* Cannabis Users: Must be interested in using cannabis for at least one of the following complains: pain, sleep problems, depression, anxiety
* Non-users: Must NOT be interested in using cannabis but have at least one of the following complaints: pain, sleep problems, depression, anxiety
* Cannabis users: must be comfortable using edible cannabis and having a mobile laboratory (Dodge van) parked at their home
* Female participants must be postmenopausal
* Comfortable reading and writing in English
* Planning to stay in the Boulder/Denver area for the next month
* Must be comfortable with blood draws
Exclusion Criteria
* Report of other drug use (cocaine, opiates, methamphetamine) in the past 90 days or fail urine screen for any of these drugs
* Past or current diagnosis of psychosis
* Current use of antipsychotic medications
* Heavy drinking; Alcohol Use Disorder Identification Test (AUDIT) test score \>8
* Inability/discomfort/unwillingness with getting in and out of the mobile laboratory van
* History of vertigo or falls within the past six months
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Colorado, Boulder
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Angela Bryan
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Colorado Boulder
Boulder, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.